Medipal Holdings Corp. in Japan is a healthcare company with a low risk ESG score of 18.4. They distribute pharmaceuticals, health, and beauty products to various medical institutions and retailers. With a focus on environment, sustainability, and governance, Medipal operates in three key segments: prescription pharmaceutical wholesale, cosmetics, daily necessities, and OTC pharmaceutical wholesale, and animal health products wholesale. The company primarily generates revenue in Japan by distributing products to hospitals, clinics, pharmacies, drugstores, convenience stores, supermarkets, animal hospitals, farms, and agricultural cooperatives.